Literature DB >> 2396018

[Gamma-ray spectra of 201Tl-radiopharmaceuticals with a scintillation camera--crosstalk of contaminating nuclides of 200Tl and/or 202Tl onto 201Tl-photopeaks].

K Saegusa1, M Fukushi, Y Katoh, H Saitoh, T Irifune.   

Abstract

In cardiac imaging with 201Tl, the collimator for low energy high resolution is generally used, and also the energy window, which is set on the spectral display of a pulse height analyzer of a scintillation camera, is chosen 70 +/- 12.5 keV. The purpose of this study is to discuss those conditions in 201Tl imaging with the scintillation camera. Two types of collimators for HR (high resolution) and ME (medium energy) were used in this experiment, and we measured the pulse height spectra of 201TlCl radiopharmaceuticals in air and in a cuboid phantom, connecting a multi-channel pulse height analyzer to the scintillation camera. As a result of measuring of the pulse height spectra, two different energies of gamma rays which are not supposed to emit from 201Tl nuclide were observed, and we also identified the presence of a small amount of 202Tl (with 439 keV) and/or 200Tl (with 368 keV) from their half-life measurements. Thus, the use of the HR-collimator with 201Tl imaging is not suitable, because the shielding effects of its septa is poor to 439 keV gamma-rays, and the scattered radiation produced by the Compton interaction contributes to the principal photopeak on the pulse height spectrum. Here, we recommend the use ME-collimator instead of the HR-one, and of the window width of 76 +/- 25 keV for increasing the count rate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396018     DOI: 10.3769/radioisotopes.39.6_255

Source DB:  PubMed          Journal:  Radioisotopes        ISSN: 0033-8303


  1 in total

1.  Degradation of myocardial perfusion SPECT images caused by contaminants in thallous (201Tl) chloride.

Authors:  Steven G Staelens; Tim C de Wit; Ignace A Lemahieu; Freek J Beekman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-25       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.